This is a routine cash-preservation compensation structure for a micro-cap biotech. No immediate trading signal. Monitor the next 10-Q for share count increases and cash burn rate to assess the real dilution impact.
Price Chart
Executive Summary
Imunon filed an 8-K disclosing that its Compensation Committee approved stock-for-salary election programs for three top executives: CEO Stacy Lindborg (up to 50% of base salary in stock, plus bonus shares of 12%-35% of the net payment), Executive Chairman Michael Tardugno (up to 100% of base salary, plus bonus shares of 20%-40%), and CMO Douglas Faller (up to 40% of base salary, plus bonus shares of 12%-15%). This is a routine compensatory arrangement with no departures or appointments — it conserves cash by paying executives in stock but also represents ongoing dilution for existing shareholders. The filing is neutral and low-impact.
Key Facts
- CEO Stacy Lindborg may elect up to 50% of base salary in common stock, with additional bonus shares of 12%-35% of the net stock payment.
- Executive Chairman Michael Tardugno may elect up to 100% of base salary in common stock, with additional bonus shares of 20%-40% of the net stock payment.
- CMO Douglas Faller may elect up to 40% of base salary in common stock, with additional bonus shares of 12%-15% of the net stock payment.
- Shares to Lindborg and Tardugno are exempt under Section 4(a)(2); shares to Faller are issued under the 2018 Stock Incentive Plan.
- No departures, resignations, or new officer appointments are disclosed.
Financial Impact
Cash conservation for a micro-cap biotech ($7M market cap) by paying executives in stock; dilution is ongoing but not quantified in absolute share or dollar terms.
Risk Factors
- Ongoing dilution from stock-based compensation to executives.
- Micro-cap biotech with $7M market cap faces high cash-burn risk; stock-for-salary programs signal cash constraints.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (IMNN) — Batch item 1 | 0001493152-26-037170 |
| Document: 0001493152-26-037170-index-headers.html | 0001493152-26-037170 |
| Document: 0001493152-26-037170-index.html | 0001493152-26-037170 |
| Document: 0001493152-26-037170.txt | 0001493152-26-037170 |
| 8-K Filing (IMNN) — Batch item 5 | 0001493152-26-037170 |
| Document: 0001493152-26-037170-index-headers.html | 0001493152-26-037170 |
| Document: 0001493152-26-037170-index.html | 0001493152-26-037170 |
| Document: 0001493152-26-037170.txt | 0001493152-26-037170 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | S-1 | $1.22 | awaiting T+5 | — | $1.23 (−0.82%) |
Oct 27, 2026 today | 8-K | $1.25 | awaiting T+5 | — | $1.23 (−1.60%) |
Oct 21, 2026 5d ago | 8-K | $1.19 | awaiting T+5 | — | $1.23 (+3.36%) |
Sep 29, 2026 27d ago | 8-K | $1.34 $1.12 | ▲ +16.10% | ▲ +18.05% | $1.23 (+7.87%) |
Aug 11, 2026 10w ago | 8-K | $1.61 $1.58 | ▼ −1.86% | ▼ −1.42% | $1.23 (−23.60%) |
Aug 11, 2026 10w ago | 8-K | $1.61 $1.58 | ▼ −1.86% | ▼ −1.46% | $1.23 (−23.60%) |
Jun 30, 2026 16w ago | 8-K | $1.88 $1.95 | ▲ +3.72% | ▲ +3.46% | $1.23 (−34.57%) |
Jun 16, 2026 18w ago | 8-K | $1.86 $1.73 | ▼ −6.99% | ▼ −5.95% | $1.23 (−33.87%) |
Jun 4, 2026 20w ago | 8-K | $2.10 $2.03 | ▲ +3.33% | ▲ +0.78% | $1.23 (+41.43%) |
May 12, 2026 23w ago | 8-K | $2.70 $2.26 | ▼ −16.30% | ▼ −16.37% | $1.23 (−54.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers